Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine local infiltration for postoperative pain after laparoscopic inguinal hernia repair
TCTR20250813001Phase 3Active, not recruiting
- Sponsor
- Universiti Kebangsaan Malaysia
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in inguinal hernia comparing Bupivacaine instillation group with Saline placebo control group (2 arms). Primary endpoints: Postoperative pain control at 1 hour, Postoperative pain control at 4 hours and 2 more. Started Apr 2025; status: active, not recruiting.
02
Drugs
bupivacaine
03
Conditions
inguinal hernia
Beyond the preview
Go deeper on TCTR20250813001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250813001.